161 – 170 of 374
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Global expression of AMACR transcripts predicts risk for prostate cancer - a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate.
- Contribution to journal › Article
-
Mark
Radioimmunotherapy for Prostate Cancer-Current Status and Future Possibilities.
- Contribution to journal › Scientific review
-
Mark
Analytical Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize the Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.
- Contribution to journal › Article
-
Mark
Oncologic and functional outcomes 1 year after radical prostatectomy for very low risk prostate cancer. Results from the prospective LAPPRO trial.
- Contribution to journal › Article
-
Mark
Low β2-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism.
- Contribution to journal › Article
-
Mark
Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide.
- Contribution to journal › Article
-
Mark
The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer.
- Contribution to journal › Article
-
Mark
The Proteome of Primary Prostate Cancer.
- Contribution to journal › Article
-
Mark
Prediction of clinical progression after radical prostatectomy in a nationwide population-based cohort
- Contribution to journal › Article
-
Mark
Making Predictive Biomarkers Readily Available
- Contribution to journal › Debate/Note/Editorial
